A citation-based method for searching scientific literature

Anne-Laure Renault, Noura Mebirouk, Eve Cavaciuti, Dorothée Le Gal, Julie Lecarpentier, Catherine Dubois d'Enghien, Anthony Laugé, Marie-Gabrielle Dondon, Martine Labbé, Gaetan Lesca, Dominique Leroux, Laurence Gladieff, Claude Adenis, Laurence Faivre, Brigitte Gilbert-Dussardier, Alain Lortholary, Jean-Pierre Fricker, Karin Dahan, Jacques-Olivier Bay, Michel Longy, Bruno Buecher, Nicolas Janin, Hélène Zattara, Pascaline Berthet, Audrey Combès, Isabelle Coupier, Janet Hall, Dominique Stoppa-Lyonnet, Nadine Andrieu, Fabienne Lesueur. Carcinogenesis 2017
Times Cited: 8







List of co-cited articles
22 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline.
N J H van Os, N Roeleveld, C M R Weemaes, M C J Jongmans, G O Janssens, A M R Taylor, N Hoogerbrugge, M A A P Willemsen. Clin Genet 2016
77
50

Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies.
Felipe Suarez, Nizar Mahlaoui, Danielle Canioni, Chantal Andriamanga, Catherine Dubois d'Enghien, Nicole Brousse, Jean-Philippe Jais, Alain Fischer, Olivier Hermine, Dominique Stoppa-Lyonnet. J Clin Oncol 2015
103
37

ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.
Anthony Renwick, Deborah Thompson, Sheila Seal, Patrick Kelly, Tasnim Chagtai, Munaza Ahmed, Bernard North, Hiran Jayatilake, Rita Barfoot, Katarina Spanova,[...]. Nat Genet 2006
469
25

Histopathological features of breast cancer in carriers of ATM gene variants.
R L Balleine, R Murali, A M Bilous, G Farshid, P Waring, P Provan, K Byth, H Thorne, J A Kirk. Histopathology 2006
12
25

Signatures of mutational processes in human cancer.
Ludmil B Alexandrov, Serena Nik-Zainal, David C Wedge, Samuel A J R Aparicio, Sam Behjati, Andrew V Biankin, Graham R Bignell, Niccolò Bolli, Ake Borg, Anne-Lise Børresen-Dale,[...]. Nature 2013
25

Ataxia-telangiectasia genes and breast cancer risk in a French family study.
Nadine Andrieu, Eve Cavaciuti, Anthony Laugé, Katia Ossian, Nicolas Janin, Janet Hall, Dominique Stoppa-Lyonnet. J Dairy Res 2005
6
33

Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia.
A L Børresen, T I Andersen, S Tretli, A Heiberg, P Møller. Genes Chromosomes Cancer 1990
111
25

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
491
25

Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.
Romain Micol, Lilia Ben Slama, Felipe Suarez, Loïc Le Mignot, Julien Beauté, Nizar Mahlaoui, Catherine Dubois d'Enghien, Anthony Laugé, Janet Hall, Jérôme Couturier,[...]. J Allergy Clin Immunol 2011
85
25

Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.
Sean V Tavtigian, Peter J Oefner, Davit Babikyan, Anne Hartmann, Sue Healey, Florence Le Calvez-Kelm, Fabienne Lesueur, Graham B Byrnes, Shu-Chun Chuang, Nathalie Forey,[...]. Am J Hum Genet 2009
119
25

Cancer predisposition of ataxia-telangiectasia heterozygotes.
M Swift, C L Chase, D Morrell. Cancer Genet Cytogenet 1990
101
25

Rare variants in the ATM gene and risk of breast cancer.
David E Goldgar, Sue Healey, James G Dowty, Leonard Da Silva, Xiaoqing Chen, Amanda B Spurdle, Mary Beth Terry, Mary J Daly, Saundra M Buys, Melissa C Southey,[...]. Breast Cancer Res 2011
126
25

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
Joaquin Mateo, Suzanne Carreira, Shahneen Sandhu, Susana Miranda, Helen Mossop, Raquel Perez-Lopez, Daniel Nava Rodrigues, Dan Robinson, Aurelius Omlin, Nina Tunariu,[...]. N Engl J Med 2015
25

Cancer risks and mortality in heterozygous ATM mutation carriers.
Deborah Thompson, Silvia Duedal, Jennifer Kirner, Lesley McGuffog, James Last, Anne Reiman, Philip Byrd, Malcolm Taylor, Douglas F Easton. J Natl Cancer Inst 2005
321
25

Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families.
N Janin, N Andrieu, K Ossian, A Laugé, M F Croquette, C Griscelli, M Debré, B Bressac-de-Paillerets, A Aurias, D Stoppa-Lyonnet. Br J Cancer 1999
82
25

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
Mary B Daly, Robert Pilarski, Michael Berry, Saundra S Buys, Meagan Farmer, Susan Friedman, Judy E Garber, Noah D Kauff, Seema Khan, Catherine Klein,[...]. J Natl Compr Canc Netw 2017
289
25

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Nasim Mavaddat, Daniel Barrowdale, Irene L Andrulis, Susan M Domchek, Diana Eccles, Heli Nevanlinna, Susan J Ramus, Amanda Spurdle, Mark Robson, Mark Sherman,[...]. Cancer Epidemiol Biomarkers Prev 2012
320
25

Identification of seven loci affecting mean telomere length and their association with disease.
Veryan Codd, Christopher P Nelson, Eva Albrecht, Massimo Mangino, Joris Deelen, Jessica L Buxton, Jouke Jan Hottenga, Krista Fischer, Tõnu Esko, Ida Surakka,[...]. Nat Genet 2013
564
25

Common variants near TERC are associated with mean telomere length.
Veryan Codd, Massimo Mangino, Pim van der Harst, Peter S Braund, Michael Kaiser, Alan J Beveridge, Suzanne Rafelt, Jasbir Moore, Chris Nelson, Nicole Soranzo,[...]. Nat Genet 2010
231
25

Melanoma genetics.
Jazlyn Read, Karin A W Wadt, Nicholas K Hayward. J Med Genet 2016
103
25

Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.
Matthew H Law, D Timothy Bishop, Jeffrey E Lee, Myriam Brossard, Nicholas G Martin, Eric K Moses, Fengju Song, Jennifer H Barrett, Rajiv Kumar, Douglas F Easton,[...]. Nat Genet 2015
139
25


Non-BRCA familial breast cancer: review of reported pathology and molecular findings.
Michael G Keeney, Fergus J Couch, Daniel W Visscher, Noralane M Lindor. Pathology 2017
14
12

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, Steven Shak, Chungyeul Kim, Joffre Baker, Wanseop Kim, Maureen Cronin, Frederick L Baehner, Drew Watson, John Bryant,[...]. J Clin Oncol 2006
12

Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma.
P G Rio, D Pernin, J O Bay, E Albuisson, F Kwiatkowski, M De Latour, D J Bernard-Gallon, Y J Bignon. Int J Oncol 1998
44
12


Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource.
Graham J Mann, Heather Thorne, Rosemary L Balleine, Phyllis N Butow, Christine L Clarke, Edward Edkins, Gerda M Evans, Sián Fereday, Eric Haan, Michael Gattas,[...]. Breast Cancer Res 2006
121
12

Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays.
Tatiana Popova, Elodie Manié, Dominique Stoppa-Lyonnet, Guillem Rigaill, Emmanuel Barillot, Marc Henri Stern. Genome Biol 2009
137
12


Leukemia and lymphoma in ataxia telangiectasia.
A M Taylor, J A Metcalfe, J Thick, Y F Mak. Blood 1996
394
12

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
Ethan Cerami, Jianjiong Gao, Ugur Dogrusoz, Benjamin E Gross, Selcuk Onur Sumer, Bülent Arman Aksoy, Anders Jacobsen, Caitlin J Byrne, Michael L Heuer, Erik Larsson,[...]. Cancer Discov 2012
12

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
Christina Curtis, Sohrab P Shah, Suet-Feung Chin, Gulisa Turashvili, Oscar M Rueda, Mark J Dunning, Doug Speed, Andy G Lynch, Shamith Samarajiwa, Yinyin Yuan,[...]. Nature 2012
12

Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention.
C Cybulski, T Huzarski, T Byrski, J Gronwald, T Debniak, A Jakubowska, B Górski, D Wokołorczyk, B Masojć, S A Narod,[...]. Clin Genet 2009
34
12

A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer.
Torsten O Nielsen, Joel S Parker, Samuel Leung, David Voduc, Mark Ebbert, Tammi Vickery, Sherri R Davies, Jacqueline Snider, Inge J Stijleman, Jerry Reed,[...]. Clin Cancer Res 2010
463
12


Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer.
V Abkevich, K M Timms, B T Hennessy, J Potter, M S Carey, L A Meyer, K Smith-McCune, R Broaddus, K H Lu, J Chen,[...]. Br J Cancer 2012
302
12


Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis.
Cezary Cybulski, Wojciech Kluźniak, Tomasz Huzarski, Dominika Wokołorczyk, Aniruddh Kashyap, Anna Jakubowska, Marek Szwiec, Tomasz Byrski, Tadeusz Dębniak, Bohdan Górski,[...]. Lancet Oncol 2015
91
12

Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region.
M G di Iasio, G Calin, M G Tibiletti, I Vorechovsky, K P Benediktsson, R Taramelli, G Barbanti-Brodano, M Negrini. Oncogene 1999
27
12

A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer.
Paz Polak, Jaegil Kim, Lior Z Braunstein, Rosa Karlic, Nicholas J Haradhavala, Grace Tiao, Daniel Rosebrock, Dimitri Livitz, Kirsten Kübler, Kent W Mouw,[...]. Nat Genet 2017
212
12

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.
Antonino Musolino, Maria A Bella, Beatrice Bortesi, Maria Michiara, Nadia Naldi, Paola Zanelli, Marzia Capelletti, Debora Pezzuolo, Roberta Camisa, Mario Savi,[...]. Breast 2007
84
12

Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations.
Guillaume Banneau, Mickaël Guedj, Gaëtan MacGrogan, Isabelle de Mascarel, Valerie Velasco, Renaud Schiappa, Valerie Bonadona, Albert David, Catherine Dugast, Brigitte Gilbert-Dussardier,[...]. Breast Cancer Res 2010
38
12

Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation.
Tatiana Popova, Elodie Manié, Guillaume Rieunier, Virginie Caux-Moncoutier, Carole Tirapo, Thierry Dubois, Olivier Delattre, Brigitte Sigal-Zafrani, Marc Bollet, Michel Longy,[...]. Cancer Res 2012
276
12

Rare, protein-truncating variants in ATM, CHEK2 and PALB2, but not XRCC2, are associated with increased breast cancer risks.
Brennan Decker, Jamie Allen, Craig Luccarini, Karen A Pooley, Mitul Shah, Manjeet K Bolla, Qin Wang, Shahana Ahmed, Caroline Baynes, Don M Conroy,[...]. J Med Genet 2017
39
12

Genomic profiling of CHEK2*1100delC-mutated breast carcinomas.
Maarten P G Massink, Irsan E Kooi, John W M Martens, Quinten Waisfisz, Hanne Meijers-Heijboer. BMC Cancer 2015
27
12

Evidence for Critical Role of Lymphocyte Cytosolic Protein 1 in Oral Cancer.
Nao Koide, Atsushi Kasamatsu, Yosuke Endo-Sakamoto, Sho Ishida, Toshihiro Shimizu, Yasushi Kimura, Isao Miyamoto, Shusaku Yoshimura, Masashi Shiiba, Hideki Tanzawa,[...]. Sci Rep 2017
18
12

Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
Pardeep Kaurah, Andrée MacMillan, Niki Boyd, Janine Senz, Alessandro De Luca, Nicki Chun, Gianpaolo Suriano, Sonya Zaor, Lori Van Manen, Cathy Gilpin,[...]. JAMA 2007
273
12

VAMP: visualization and analysis of array-CGH, transcriptome and other molecular profiles.
Philippe La Rosa, Eric Viara, Philippe Hupé, Gaëlle Pierron, Stéphane Liva, Pierre Neuvial, Isabel Brito, Séverine Lair, Nicolas Servant, Nicolas Robine,[...]. Bioinformatics 2006
92
12

In silico analysis of missense substitutions using sequence-alignment based methods.
Sean V Tavtigian, Marc S Greenblatt, Fabienne Lesueur, Graham B Byrnes. Hum Mutat 2008
145
12

GENESIS: a French national resource to study the missing heritability of breast cancer.
Olga M Sinilnikova, Marie-Gabrielle Dondon, Séverine Eon-Marchais, Francesca Damiola, Laure Barjhoux, Morgane Marcou, Carole Verny-Pierre, Valérie Sornin, Lucie Toulemonde, Juana Beauvallet,[...]. BMC Cancer 2016
6
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.